SIGA rises on antiviral drug orders worth $16 mln

SIGA Technologies

26/09/2022 15:44

** Shares of SIGA Technologies Inc  SIGA.O  rise 2.7% to
$10.56
    ** Company says it has received new orders worth about $16
mln for its oral antiviral drug Tpoxx in August and September
amid the monkeypox outbreak
    ** Including recent orders, SIGA has received about $76 mln
of international orders for oral Tpoxx
    ** Company expects to complete delivery of the most recent
orders in 2022
    ** Oral and intravenous formulations of Tpoxx are already
approved by U.S. FDA for treating smallpox
    ** Including session gains, company's shares up ~49.4% YTD
 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com))